Lunenfeld-Tanenbaum Research Institute

What Lunenfeld-Tanenbaum Research Institute does

Lunenfeld-Tanenbaum Research Institute (LTRI) is a private nonprofit biomedical research institute headquartered at 600 University Avenue in Toronto, Ontario, with a secondary site at 60 Murray Street within the Frances Bloomberg Centre for Women's and Infants' Health at Mount Sinai Hospital. The institute is the research arm of Sinai Health and is affiliated with the University of Toronto's Faculty of Medicine. It employs 101-250 staff and serves academic researchers and clinicians conducting research in cancer, pregnancy complications, and developmental disorders, while operating as one of the older and more established biomedical research centers in Canada (legacy operations traceable to 1997).

LTRI's product is shared research infrastructure organized around six core platforms: the Network Biology Collaborative Centre (NBCC) offering proteomics mass spectrometry, next-generation sequencing, high-throughput screening, high-content screening, and high-resolution imaging; the Centre for Phenogenomics providing mouse model production, clinical phenotyping, pathology, and cryopreservation; the RCWIH BioBank holding over 9,000 perinatal specimens with detailed clinical profiles and 1,500+ PFPE tissue blocks; a Biospecimen Repository and Processing Lab; the Research Trainee Centre for trainee support; and the SciHigh community outreach program. Technology differentiators include a Nikon Centre of Excellence partnership providing early access to STEDYCON (30 nm resolution), SoRa/DeepSIM (~100 nm resolution), A1R confocal, and Zeiss AxioScan slide-scanning systems, plus electron microscopy through the Hospital for Sick Children Advanced Bioimaging Centre.

The institute's revenue model combines competitive grant funding (e.g., USD $3M+ from Mark Foundation for Cancer Research and Sontag Foundation for glioblastoma research in Feb 2026; support from Canada Foundation for Innovation, Ontario Government, and Mitacs), philanthropic donations routed through the Sinai Health Foundation, and cost-recovery fee-for-service pricing on platform usage (e.g., USD $35/hr for confocal imaging, $108/hr for super-resolution, $3-$22/slide on scanners). Pricing is publicly disclosed for external academic users and billed on a pay-as-you-go basis; biospecimens are provided without charge for the donated tissue itself. Customer segments are primarily horizontal: principal investigators, clinician scientists, staff scientists, and trainees within Sinai Health, the University of Toronto, and external academic institutions globally. Distribution is direct via platform booking and specimen request workflows.

Name

Lunenfeld-Tanenbaum Research Institute

Legal name

Lunenfeld-Tanenbaum Research Institute

Website

https://lunenfeld.ca

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

101–250 employees

Short description

Lunenfeld-Tanenbaum Research Institute (LTRI) is a Toronto-based nonprofit biomedical research institute and the research arm of Sinai Health, affiliated with the University of Toronto. It operates shared platforms including proteomics, genomics, advanced imaging, phenogenomics, and the RCWIH perinatal BioBank serving academic and clinical researchers.

Ownership category

akta.pro rank

Product category

Biomedical Research Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)

akta.pro secondary industry

Proteomics & Mass Spectrometry Services (HLAGANAB)

Keywords

• Biomedical research services
• Proteomics and genomics
• Advanced imaging services
• Biospecimen biorepository
• Phenogenomics services

Headquarters

HQ city

Toronto

HQ country

Canada

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Others

Pricing tiers

Distribution channels2 records

Marketing channels4 records

Core offering

Lunenfeld-Tanenbaum Research Institute operates shared technology platforms and core facilities that deliver biomedical research services to internal Sinai Health investigators and external academic clients. Core offerings include proteomics mass spectrometry, next-generation sequencing, high-throughput and high-content screening, advanced super-resolution/confocal/widefield imaging, mouse model production and phenotyping, and a perinatal biospecimen biorepository, all delivered on a cost-recovery or grant-funded basis.

Product overview

Lunenfeld-Tanenbaum Research Institute operates as one of the world's top biomedical research institutes and one of Canada's leading biomedical research facilities. The institute provides a platform of shared technology platforms and core facilities rather than commercial products. The core offerings include the Network Biology Collaborative Centre (NBCC) offering proteomics, sequencing, and imaging services; The Centre for Phenogenomics for mouse model services; the RCWIH BioBank for human perinatal specimens; the Biospecimen Repository for storage and distribution; Nanoscale Imaging through partnership; and Optima Imaging for advanced microscopy. These technology platforms operate as shared research infrastructure accessible to scientists at the institute and external researchers.

Differentiator

Problem solved

Functional benefit

Products and services

• Network Biology Collaborative Centre (NBCC) World-class research infrastructure offering proteomics mass spectrometry, high-throughput screening, high-content screening, high-resolution imaging, and next-generation sequencing services to internal and external scientists.
• The Centre for Phenogenomics Provides mouse holding, mouse model production, clinical phenotyping imaging, pathology, and cryopreservation and recovery services for biomedical researchers.
• RCWIH BioBank Biorepository providing human placental tissue and clinical specimens collected under strict ethical guidelines, supporting perinatal and women's health research with over 9,000 specimens and detailed clinical profiles.
• Biospecimen Repository and Processing Lab (BSR) Provides biospecimen storage, processing, and distribution services for high-quality research biospecimens to support biomedical research projects.
• Advanced Imaging Facility Provides super-resolution imaging (STEDYCON up to 30nm, SoRa/DeepSIM up to ~100nm), confocal imaging, widefield imaging, whole-slide scanning, and live-cell imaging with image analysis support using Visiopharm, NIS Elements, Volocity, CellProfiler, and ImageJ.
• Optima Imaging Fluorescence and brightfield microscopy services including SPIM lightsheet imaging technology for biomedical researchers.
• Nanoscale Imaging Electron microscopy services provided through partnership with The Hospital for Sick Children Advanced Bioimaging Centre for nanoscale biomedical imaging.

Quantifiable outcome

• 104 publications supported using RCWIH BioBank specimens as of January 2017
• +1 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature5 records

Partnerships

Five partnerships are on record, tiered core, major and strategic.

• Sinai HealthcoreOthersLTRI is the research arm of Sinai Health System, one of Canada's leading academic healthcare organizations
• University of TorontocoreStrategic or Co-development PartnerAffiliated with University of Toronto Faculty of Medicine; investigators hold professorships in Department of Molecular Genetics
• Nikon CanadamajorTechnology or IntegrationNikon Centre of Excellence at Lunenfeld-Tanenbaum provides early access to advanced instrumentation and data analysis workflows for imaging
• MitacsstrategicStrategic or Co-development PartnerMitacs Honorary Partner; collaboration on research training and innovation programs
• Mount Sinai HospitalcoreStrategic or Co-development PartnerRCWIH BioBank is located within Mount Sinai Hospital and works closely with clinical staff for specimen collection

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Eurofins Scientific: Global contract laboratory services provider with proteomics, genomics, and bioanalytical capabilities. Comparable as a contract lab services provider in proteomics/mass spectrometry and biospecimen testing that competes for external academic users.
• WuXi AppTec: Global CRO/CDMO with extensive proteomics, genomics, bioanalytical, and preclinical services. Comparable as a commercial lab services provider offering research platforms at large scale that competes with academic core facilities for external user demand.
• Broad Institute: MIT/Harvard-affiliated nonprofit biomedical and genomic research institute with genome sequencing, proteomics, and chemical biology platforms. Comparable as a university-affiliated nonprofit research institute operating core genomics/proteomics facilities at significantly larger scale.
• Charles River Laboratories: Global commercial CRO providing preclinical research services, model organism production, and laboratory services. Comparable as a provider of fee-for-service phenogenomics, biospecimen, and discovery research services, though at much larger commercial scale.
• Allen Institute for Cell Science: Seattle-based nonprofit research organization focused on cell biology, high-content imaging, and computational analysis. Comparable as a private nonprofit research organization with advanced imaging, HCS, and AI-driven analysis platforms of similar architectural design.

Direct peers

• Stowers Institute for Medical Research: Private nonprofit biomedical research organization with model organism, imaging, and proteomics core facilities, supported by an endowment model. Comparable in operating model as a private nonprofit multi-platform biomedical research institute.
• Princess Margaret Cancer Centre Research: Major Canadian oncology research centre within UHN offering translational research programs and biobank services. Comparable as an AMC-affiliated cancer research platform with similar biorepository and translational medicine focus areas.
• Ontario Institute for Cancer Research (OICR): Toronto-based, Ontario-funded cancer research institute with genomic, proteomic, and bioinformatics platforms. Operates as a complementary provincial research institute with overlapping cancer genomics and translational research capabilities.
• University Health Network Research: Toronto-based research enterprise within University Health Network operating major core facilities, biospecimen resources, and disease-focused research programs. Closely comparable as a multi-hospital-affiliated research platform serving the same Ontario research ecosystem.
• The Hospital for Sick Children Research Institute: Toronto-based pediatric biomedical research institute with comparable proteomics, imaging, and model organism capabilities. Operates in the same Discovery District ecosystem with overlapping academic medical center affiliations and similar technology platform offerings, including the Advanced Bioimaging Centre which LTRI partners with for electron microscopy.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/nbcc_ltri
• LinkedInlinkedin.com/company/lunenfeld-tanenbaum-research-institute-sinai-health

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Subsidiaries6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lunenfeld-Tanenbaum Research Institute